Adar Poonawalla further said Serum Institute of India (SII) will make 6-7 million doses of Covishield available in 90 days and it could take up to nine months to further build up the stock based on demand.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zaRP0gD
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield
0 comments:
Post a Comment